Coronavirus

The Pharmacy Times® Coronavirus resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Greater Health Care Lessons for Pharmacy and Beyond in the COVID-19 Crisis
What can we help you find?
[[thumbnail_alt_text]]
The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with temperate climates, but only when herd immunity is attained through natural infection or vaccinations.
[[thumbnail_alt_text]]
The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy. 
[[thumbnail_alt_text]]
Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.
 
[[thumbnail_alt_text]]
Although working from home created challenges for contacting stakeholders, some companies saw higher accuracy and fewer sick days among employees.
[[thumbnail_alt_text]]
The keynote presentation will be broadcast virtually on 4 dates this fall and highlight cancer-specific guidance for pharmacists during the COVID-19 pandemic.
[[thumbnail_alt_text]]
A study of Chinese women found COVID-19 heightened stress, fear, and depression during pregnancy. 
 
[[thumbnail_alt_text]]
Following the global impact of COVID-19 on the health care system in 2020, there have been some clear changes in HIV care in the United States.
[[thumbnail_alt_text]]
The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.
[[thumbnail_alt_text]]
Students at the University of Illinois at Chicago College of Pharmacy answered the question “How has the pandemic impacted your summer internship/residency (or other pharmacy work)?”  
[[thumbnail_alt_text]]
In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.
[[thumbnail_alt_text]]
Although the presence of rhinovirus limited the ability of influenza to infect cells, researchers do not know whether the same effect will be seen with COVID-19.